Zobrazeno 1 - 10
of 6 081
pro vyhledávání: ''
Publikováno v:
British Journal of Clinical Pharmacology. 88(3):1211-1222
Aims Musculoskeletal toxicity is a typical side effect of daptomycin (DAP). However, the risk factors have not been well established. Here, we aimed to identify independent factors affecting DAP-induced musculoskeletal toxicity using a combination of
Autor:
Yuma A. Bijleveld, Adam F. Cohen, Michiel J van Esdonk, Gertjan J. Driessen, Anton H. van Kaam, Matthijs D. Kruizinga, Ron A. A. Mathôt, Willemijn van Heel, Rik F E Stuurman, Younes Tallahi, Amadou Samb, Timo R. de Haan
Publikováno v:
British Journal of Clinical Pharmacology, 88(4), 1845-1855. Wiley
British journal of clinical pharmacology. Wiley-Blackwell
British journal of clinical pharmacology. Wiley-Blackwell
Aims Therapeutic drug monitoring (TDM) of gentamicin in neonates is recommended for safe and effective dosing and is currently performed by plasma sampling, which is an invasive and painful procedure. In this study, feasibility of a non-invasive gent
Autor:
Camille Philip, Hélène Peyrière, Marion Soler, Hélène Donnadieu-Rigole, Agnès Muller, Sophie Roy, François Georgin, Céline Eiden, Marie-Christine Picot
Publikováno v:
British Journal of Clinical Pharmacology. 88:2306-2314
AIMS Community pharmacists could contribute to identify people misusing prescription opioids, which may be associated with hospitalizations, substance use disorders, and death. This study investigated prescription opioid misuse in community pharmacy
Autor:
Xiangyang Zhang, Wei Hao, Baoqiang Guo, Jinni Chen, Ruiling Zhang, Songyin Gao, Desheng Zhai, Ying Zhao, Ravi Retnakaran, Shi Wu Wen
Publikováno v:
British Journal of Clinical Pharmacology. 88:2297-2305
Aim Hypothyroxinemia might be easily ignored, due to attention is typically paid to individuals with elevated thyroid stimulating hormone (TSH). In this study, we aimed to evaluate the association of oxcarbazepine use as adjuvant for treatment of sch
Publikováno v:
British Journal of Clinical Pharmacology. 88:2019-2034
Aim Anti-human epidermal growth factor receptor 2 (HER2) therapy is an effective treatment for HER2-positive gastric and breast malignancies. However, the efficacy of HER2-targeted therapy in non-small cell lung cancer (NSCLC) patients with HER2 alte
Autor:
Alicia Probst, Emilie De Carli, Isabelle Aerts, Pascal Chastagner, Natacha Entz-Werle, Caroline Solas, Anne-Isabelle Bertozzi-Salamon, Nicolas André, Anne Pagnier, Emmanuelle Tresch-Bruneel, Pierre Leblond, Jacques Grill, Didier Frappaz, Mourad Hamimed, Florence Gattacceca
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15131⟩
AIM There is a crucial need for pharmacokinetic (PK) data of oral vinorelbine (VNR) in pediatric population. The aim of this work was to assess the PK profile of orally administered VNR in children with recurrent/progressive primary low-grade glioma
Autor:
Ashley Woodcock, Alexander Wilkinson
Publikováno v:
British Journal of Clinical Pharmacology. 88:3016-3022
The propellants in metered-dose inhalers (MDIs) are powerful greenhouse gases, which account for approximately 13% of the NHS's carbon footprint related to the delivery of care. Most MDI use is in salbutamol relievers in patients with poorly controll
Publikováno v:
British Journal of Clinical Pharmacology. 88:2484-2499
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease and is usually diagnosed in childhood, especially in the first decade of life. Paediatric FMF is characterized by a protean clinical expression and a variable th
Autor:
Nadia Gaudel, Dorothée Semiond, Hoai-Thu Thai, Helgi van de Velde, Jean-Baptiste Fau, Geraldine Ayral, Christine Veyrat-Follet, Marc Cerou, Bernard Sebastien
Publikováno v:
British Journal of Clinical Pharmacology. 88:2052-2064
Aims Addition of isatuximab to pomalidomide/dexamethasone (Pd) significantly improved progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma (RRMM). We aimed to characterize the relationship between serum M-protein kine
Autor:
Fermín Sánchez-Guijo, Silvia Jiménez Cabrera, Otero Mj, Aránzazu Zarzuelo Castañeda, Álvaro Corral Alaejos, Jonás Samuel Pérez-Blanco
Publikováno v:
British Journal of Clinical Pharmacology. 88:1913-1924
Aims Imatinib is considered the standard first line treatment in newly diagnosed patients with chronic-phase myeloid leukaemia (CML). Several imatinib population pharmacokinetic (popPK) models have been developed. However, their predictive performanc